Covidence vs Rayyan: An Honest Screening Tool Comparison

In the Covidence vs Rayyan decision, both tools dominate the systematic review screening software market, and the choice shapes your team's daily workflow for months. Here's an honest comparison based on what each actually does well, and where each falls short.

Covidence: structured, end-to-end, and paid

Covidence covers the full review pipeline: import and deduplication, title and abstract screening, full-text screening, risk-of-bias assessment, and data extraction, all inside one connected platform. Its structure is opinionated, which is generally a strength for teams that want a guided process rather than a flexible one.

**Where it's strong:** the deduplication tool is genuinely reliable across multiple database export formats, the screening interface clearly flags reviewer conflicts for resolution, and having risk-of-bias and extraction built into the same platform as screening keeps your workflow in one place rather than exporting between tools.

**Where it falls short:** it's subscription-based, and cost is a real factor for independent researchers or smaller teams without institutional access. The extraction forms, while functional, are less flexible than a purpose-built spreadsheet for reviews with unusual or highly granular data needs. Institutional access through a university library is common and worth checking before assuming you need to pay individually.

Rayyan: free, flexible, and screening-focused

Rayyan is free for standard use, with a paid tier for advanced features like team management at scale. It focuses specifically on the screening stage rather than covering the full pipeline, and its blinding features (a "blind" mode that hides other reviewers' decisions until you submit your own) are particularly well regarded for maintaining genuine independent screening.

**Where it's strong:** free for most use cases makes it the default choice for reviewers without institutional software budgets, its machine-learning-assisted ranking (predicting likely relevant records to help prioritize screening order) is a genuinely useful triage aid, and its interface is fast and uncluttered for high-volume screening.

**Where it falls short:** it doesn't handle risk-of-bias assessment or data extraction, so you'll need a separate tool or spreadsheet for those stages, meaning your workflow spans more than one platform. Its deduplication, while functional, is generally considered less thorough than Covidence's for messy, inconsistently formatted database exports.

How to actually choose

**Choose Covidence if:** your team wants one platform covering screening through extraction, you have institutional access or budget for a subscription, and you value a more guided, structured workflow over flexibility.

**Choose Rayyan if:** budget is a genuine constraint, you're comfortable managing extraction and risk-of-bias assessment in a separate tool or spreadsheet, and you want the fastest, leanest screening-specific interface.

**A common hybrid approach:** some teams use Rayyan for screening (taking advantage of its cost and blinding features) and then move to a structured spreadsheet or a separate extraction tool for the later stages, rather than paying for Covidence's full pipeline when only the screening stage genuinely needs dedicated software.

What doesn't change regardless of tool

Whichever platform you choose, dual independent screening, documented conflict resolution, and a reproducible export of your screening decisions for the PRISMA flow diagram are non-negotiable, not features either tool automates away. The software manages logistics; the methodological rigor is still yours to maintain.

**[Get a quote](/systematic-reviews#literature-search-strategy)** if you'd like help setting up your screening workflow, whichever tool you choose.